National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Phase 2
1999-07-01
Rheumatoid arthritis (RA) is an autoimmune disease characterized by swelling and inflammation
of the joints. In RA, the immune system attacks a person's own cells inside joints,
eventually leading to joint damage and disability. This study will determine if oral bovine
type II collagen (bovine CII) will lead to decreased joint inflammation in RA patients.
Rheumatoid arthritis (RA) is an autoimmune disease characterized by swelling and inflammation
of the joints. In RA, the immune system attacks a person's own cells inside joints,
eventually leading to joint damage and disability. This study will determine if oral bovine
type II collagen (bovine CII) will lead to decreased joint inflammation in RA patients.
An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection
Completed
National Institute of Allergy and Infectious Diseases (NIAID)
N/A
1969-12-31
To restore immunologic function and virus-free state in HIV-infected patients. Based on
previous studies showing temporary improvement in immune function in HIV-infected patients
using peripheral lymphocyte transfers and bone marrow transplantation, and based on studies
documenting the antiretroviral effects of zidovudine (AZT) and interferon-alfa (IFN-A) as
well as the preliminary test tube and patient studies suggesting anti-HIV effects of
recombinant CD4-IgG, we propose to treat HIV-infected patients using combination
antiretroviral therapy with transplantation of bone marrow and peripheral lymphocytes from
previously immunized donors in an attempt to restore immunologic function and a virus-free
state.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
